Neuroblastoma: open trials in Netherlands

9 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-10-30
2023-504880-18-00
A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-05-07
2024-514089-37-00
Indocyanine Green and near infrared fLuorescence in paediatric Oncology surgery
Trial Treatment · Phase 2 · The University Of Birmingham
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2026-04-30
NCT07399821
An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Prinses Máxima Centrum, Utrecht
Registry updated 2026-02-10
NCT07334301
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Trial Treatment · Phase 1/2 · University of Birmingham
Princess Maxima Center Utrecht, Utrecht
Registry updated 2026-01-12
2022-501694-39-01
mFBG PET-CT for neuroblastoma
Trial Treatment · Phase 1/2 · Princess Maxima Center For Pediatric Oncology
Princess Máxima Center for Pediatric Oncology, Utrecht
Registry updated 2025-10-16
NCT06485947
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
Trial Treatment · Phase 1 · Princess Maxima Center for Pediatric Oncology
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2025-07-08
NCT04221035
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Universitair Medisch Centrum Groningen, Groningen · Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2025-06-26
NCT04903899
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
Trial Treatment · Phase 2 · Jakob Stenman
Prinses Maxima Centrum voor Kinderoncologie B.V., Utrecht
Registry updated 2025-02-11

All Neuroblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error